tirzepatide package insert These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO.MOUNJARO® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 2022 Mountainside Medical (SDVOSB) is a medical supplies and pharma distributor with low wholesale prices on injections and medications for doctors. Mounjaro Injection: Package Insert /

Results were that the composite outcome was significantly less in the empagliflozin group compared to placebo [10.5% vs

Dual GIP and GLP-1 medications, including tirzepatide, slow the movement of food through the digestive tract, making constipation more likely

Significant Weight Loss: Studies show Mounjaro leads to substantial weight reduction, outperforming other medications or lifestyle changes

supplementation may be beneficial Individuals with gastrointestinal conditions : Coeliac disease, Crohn's disease, or previous gastric surgery affect nutrient absorption Women with heavy menstrual periods : Increased iron requirements may necessitate supplementation Pregnant and breastfeeding women : Increased nutritional demands require careful dietary planning

(6) Glenn JM, et al